Form D · Other Health Care
Glycotest Inc.
Merion Station, PA · CIK 0002144866
Offering snapshot reported Jul 16, 2026 · SEC filing
- Reported sold
- $3.22M Offering amount: $6.8M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 16, 2026 | Initial | $3,220,105 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $77.4K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-591103
Includes a commission to EMV Capital Partners of 6-9% of the amount invested by MNL Nominees Limited. Neither party solicited U.S. investors or received commission for investments by U.S. investors.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| EMV Capital Partners | None |
Source: Form D, filed Jul 16, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ed Hooper | Director |
| Ilian Iliev | Director |
| Jenny Jiang | Director |
| Charles Swindell | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
613 Schiller Ave.
Merion Station, PA, 19066
Merion Station, PA, 19066